Completed NA INTERVENTIONAL 2-arm NCT02796664

Preventive Effects of Ginseng Against Atherosclerosis (PEGASUS)

Preventive Effects of Ginseng Against Atherosclerosis and Subsequent Ischemic Stroke: A Randomized Controlled Trial

Sponsor: Dae Chul Suh

Conditions Atherosclerosis Ischemic Stroke

Updated 9 times since 2017 Last updated: Aug 2, 2021 Started: Jun 23, 2016 Primary completion: Jul 4, 2018 Completion: Jul 4, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Atherosclerosis and Ischemic Stroke, this trial is completed. The trial is conducted by Dae Chul Suh and has accumulated 9 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2021 — Jul 2024 [monthly]

Completed NA
Sep 2021 — Dec 2021 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE4 → NA

▶ Show 4 earlier versions

Jan 2021 — Sep 2021 [monthly]

Unknown Status PHASE4
Aug 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Aug 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dae Chul Suh
Korea Ginseng Corporation

Data source: Asan Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea